677 related articles for article (PubMed ID: 19229742)
21. A prospective study of Mohs' micrographic surgery in two English centres.
Julian CG; Bowers PW
Br J Dermatol; 1997 Apr; 136(4):515-8. PubMed ID: 9155950
[TBL] [Abstract][Full Text] [Related]
22. Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. I. Characteristics of the tumours and details of the procedure.
Lindgren G; Lindblom B; Bratel AT; Mölne L; Larkö O
Acta Ophthalmol Scand; 2000 Aug; 78(4):425-9. PubMed ID: 10990045
[TBL] [Abstract][Full Text] [Related]
23. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
24. Periocular microcystic adnexal carcinoma: management and outcome with Mohs' micrographic surgery.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Ophthalmologica; 2006; 220(2):109-13. PubMed ID: 16491033
[TBL] [Abstract][Full Text] [Related]
25. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous lip tumours treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Selva D; Paver R; Richards S
Br J Dermatol; 2005 Dec; 153(6):1147-52. PubMed ID: 16307650
[TBL] [Abstract][Full Text] [Related]
27. Mohs' micrographic surgery for Merkel cell carcinomas of the eyelid.
Pathai S; Barlow R; Williams G; Olver J
Orbit; 2005 Dec; 24(4):273-5. PubMed ID: 16354638
[TBL] [Abstract][Full Text] [Related]
28. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery.
Spencer JM; Nossa R; Tse DT; Sequeira M
J Am Acad Dermatol; 2001 Jun; 44(6):1004-9. PubMed ID: 11369914
[TBL] [Abstract][Full Text] [Related]
29. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
Villalon-Lopez JS; Valle-Mejia CA; Patino-Lara A; Moreno-Perez BA; Munoz-Lopez JA; Alcantar-Andrade A
J Cancer Res Ther; 2006; 2(3):140-3. PubMed ID: 17998694
[TBL] [Abstract][Full Text] [Related]
30. Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. II. Reconstruction and follow-up.
Lindgren G; Lindblom B; Larkö O
Acta Ophthalmol Scand; 2000 Aug; 78(4):430-6. PubMed ID: 10990046
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
32. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
Hamada S; Kersey T; Thaller VT
Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
[TBL] [Abstract][Full Text] [Related]
33. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
[TBL] [Abstract][Full Text] [Related]
34. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
36. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
[TBL] [Abstract][Full Text] [Related]
37. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
[TBL] [Abstract][Full Text] [Related]
38. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
39. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
Lawrence CM; Haniffa M; Dahl MG
Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
[TBL] [Abstract][Full Text] [Related]
40. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial.
Smeets NW; Krekels GA; Ostertag JU; Essers BA; Dirksen CD; Nieman FH; Neumann HA
Lancet; 2004 Nov 13-19; 364(9447):1766-72. PubMed ID: 15541449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
